We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
Turnover
20%
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+41.71%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$336M
AUM Growth
+$172M
(+104%)
Cap. Flow
+$87.6M
Cap. Flow
% of AUM
26.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Repare Therapeutics
RPTX
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM
MPM Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, MPM Asset Management held 6 positions worth $336M, up 104% from $164M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MPM Asset Management deployed $87.6M of net new capital in Q2 2020, opening 1 new position. Its largest new stake was Repare Therapeutics: 3,003,772 shares worth $93.2M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $8.77M trimmed.
- MPM Asset Management's largest Q2 2020 buy was Repare Therapeutics: 3,003,772 shares worth $93.2M.
- MPM Asset Management's biggest Q2 2020 reduction was Rhythm Pharmaceuticals, cutting an estimated $8.77M.
- MPM Asset Management's ten largest holdings make up 100% of its $336M portfolio in Q2 2020.
- MPM Asset Management opened 1 new position and closed 0 in Q2 2020.
- MPM Asset Management's portfolio value rose 104% quarter-over-quarter to $336M.
Based on MPM Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.